BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 13129634)

  • 21. Point A vs. HR-CTV D
    Harmon G; Diak A; Shea SM; Yacoub JH; Small W; Harkenrider MM
    Brachytherapy; 2016; 15(6):825-831. PubMed ID: 27693173
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inter fraction variations in rectum and bladder volumes and dose distributions during high dose rate brachytherapy treatment of the uterine cervix investigated by repetitive CT-examinations.
    Hellebust TP; Dale E; Skjønsberg A; Olsen DR
    Radiother Oncol; 2001 Sep; 60(3):273-80. PubMed ID: 11514007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dosimetric analysis at ICRU reference points in HDR-brachytherapy of cervical carcinoma.
    Eich HT; Haverkamp U; Micke O; Prott FJ; Müller RP
    Rontgenpraxis; 2000; 53(2):62-6. PubMed ID: 10994367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison between the ICRU rectal point and modern volumetric parameters in brachytherapy for locally advanced cervical cancer.
    Mazeron R; Kamsu Kom L; Rivin del Campo E; Dumas I; Farha G; Champoudry J; Chargari C; Martinetti F; Lefkopoulos D; Haie-Meder C
    Cancer Radiother; 2014 Jun; 18(3):177-82. PubMed ID: 24751222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dose and volume parameters for MRI-based treatment planning in intracavitary brachytherapy for cervical cancer.
    Kirisits C; Pötter R; Lang S; Dimopoulos J; Wachter-Gerstner N; Georg D
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):901-11. PubMed ID: 15936576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deformable image registration-based contour propagation yields clinically acceptable plans for MRI-based cervical cancer brachytherapy planning.
    Chapman CH; Polan D; Vineberg K; Jolly S; Maturen KE; Brock KK; Prisciandaro JI
    Brachytherapy; 2018; 17(2):360-367. PubMed ID: 29331573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inverse planning approach for 3-D MRI-based pulse-dose rate intracavitary brachytherapy in cervix cancer.
    Chajon E; Dumas I; Touleimat M; Magné N; Coulot J; Verstraet R; Lefkopoulos D; Haie-Meder C
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):955-61. PubMed ID: 17889277
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of bladder dose points for assessment of the spatial dose distribution in the posterior bladder wall in cervical cancer brachytherapy and the impact of applicator position.
    Nkiwane KS; Pötter R; Fokdal LU; Hoskin P; Pearcey R; Segedin B; Mahantshetty U; Kirisits C
    Brachytherapy; 2015; 14(2):252-9. PubMed ID: 25530424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison between revised Manchester Point A and ICRU-89-recommended Point A definition absorbed-dose reporting using CT images in intracavitary brachytherapy for patients with cervical carcinoma.
    Mourya A; Choudhary S; Shahi UP; Sharma N; Gautam H; Patel G; Pradhan S; Aggarwal LM
    Brachytherapy; 2021; 20(1):118-127. PubMed ID: 32811759
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inter-observer variation in delineation of bladder and rectum contours for brachytherapy of cervical cancer.
    Saarnak AE; Boersma M; van Bunningen BN; Wolterink R; Steggerda MJ
    Radiother Oncol; 2000 Jul; 56(1):37-42. PubMed ID: 10869753
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Organ movements and dose exposures in teletherapy of prostate cancer using a rectal balloon.
    Elsayed H; Bölling T; Moustakis C; Müller SB; Schüller P; Ernst I; Willich N; Könemann S
    Strahlenther Onkol; 2007 Nov; 183(11):617-24. PubMed ID: 17960337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of computed tomography and magnetic resonance imaging in cervical cancer brachytherapy target and normal tissue contouring.
    Eskander RN; Scanderbeg D; Saenz CC; Brown M; Yashar C
    Int J Gynecol Cancer; 2010 Jan; 20(1):47-53. PubMed ID: 20130502
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Can point doses predict volumetric dose to rectum and bladder: a CT-based planning study in high dose rate intracavitary brachytherapy of cervical carcinoma?
    Patil VM; Patel FD; Chakraborty S; Oinam AS; Sharma SC
    Br J Radiol; 2011 May; 84(1001):441-8. PubMed ID: 21511749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of organs at risk doses in GYN intracavitary brachytherapy for different tandem lengths and bladder volumes.
    Siavashpour Z; Aghamiri MR; Jaberi R; ZareAkha N; Manshadi HRD; Kirisits C; Sedaghat M
    J Appl Clin Med Phys; 2016 May; 17(3):5-13. PubMed ID: 27167253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiography-based treatment planning compared with computed tomography (CT)-based treatment planning for intracavitary brachytherapy in cancer of the cervix: analysis of dose-volume histograms.
    Kim RY; Pareek P
    Brachytherapy; 2003; 2(4):200-6. PubMed ID: 15062127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modeling normal tissue complication probability from repetitive computed tomography scans during fractionated high-dose-rate brachytherapy and external beam radiotherapy of the uterine cervix.
    Dale E; Hellebust TP; Skjønsberg A; Høgberg T; Olsen DR
    Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):963-71. PubMed ID: 10863066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of dosimetric and clinical parameters on clinical side effects in cervix cancer patients treated with 3D pulse-dose-rate intracavitary brachytherapy.
    Levitchi M; Charra-Brunaud C; Quetin P; Haie-Meder C; Kerr C; Castelain B; Delannes M; Thomas L; Desandes E; Peiffert D
    Radiother Oncol; 2012 Jun; 103(3):314-21. PubMed ID: 22633813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dynamics of High Risk Clinical Target Volume reduction during Brachytherapy and impact on its coverage in patients with inoperable cervical cancer.
    Pobijakova M; Scepanovic D; Paluga M; Fekete M; Mardiak J
    Neoplasma; 2018 Mar; 65(3):425-430. PubMed ID: 29788726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Dosimetry methods in determining radiation dosage of the rectum in HDR-brachytherapy of cervix carcinoma].
    Eich HT; Haverkamp U; Micke O; Prott FJ; Pötter R
    Strahlenther Onkol; 1998 Jul; 174(7):375-80. PubMed ID: 9689959
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Computed tomography-based high-dose-rate intracavitary brachytherapy for uterine cervical cancer: preliminary demonstration of correlation between dose-volume parameters and rectal mucosal changes observed by flexible sigmoidoscopy.
    Koom WS; Sohn DK; Kim JY; Kim JW; Shin KH; Yoon SM; Kim DY; Yoon M; Shin D; Park SY; Cho KH
    Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1446-54. PubMed ID: 17482766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.